Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Revenue

Cohance Lifesciences had revenue of 5.45B INR in the quarter ending December 31, 2025, with 77.29% growth. This brings the company's revenue in the last twelve months to 10.79B, up 2.90% year-over-year. In the fiscal year ending March 31, 2025, Cohance Lifesciences had annual revenue of 11.98B with 13.91% growth.

• Revenue (ttm): 10.79B
• Revenue Growth: +2.90%
• P/S Ratio: 16.98
• Revenue / Employee: 8.90M
• Employees: 1,212
• Market Cap: 183.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	11.98B	1.46B	13.91%
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	1.52%
Mar 31, 2022	13.20B	3.11B	30.75%
Mar 31, 2021	10.10B	1.76B	21.10%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error